Day: July 29, 2025

Utrecht, 29 July 2025, Aalberts today reports that it has repurchased 145,500 of its own shares in the period from 21 July 2025, up to and including 25 July 2025, for an amount of EUR 4,011,589.94, so at an average share price of EUR 27.57. This is part of the share buyback programme as announced on 27 February 2025, for a total amount of EUR 75 million. The repurchase of shares commenced on 28 February 2025 and will be completed no later than 24 October 2025. It is intended that the shares will be cancelled following repurchase. Up to and including 25 July 2025, a cumulative total of 2,150,324 shares was repurchased under the share buyback programme for a total consideration of EUR 63,810,716. Aalberts has engaged an intermediary to repurchase the Aalberts shares in the open market, during open and closed periods, independent of Aalberts. The...

Study to evaluate the efficacy and safety of fosmanogepix in adults with invasive mold infections Study completion expected in Q1 2028Allschwil, Switzerland, July 29, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today the initiation of FORWARD-IM, a phase 3 registrational study evaluating the efficacy and safety of its broad-spectrum antifungal fosmanogepix for the treatment of adult patients with invasive mold infections.[1] Fosmanogepix is a first-in-class antifungal with a novel mechanism of action and is available in both intravenous and oral formulations. It has been evaluated for efficacy and safety in a phase 1 and phase 2 program, including three open-label phase 2 studies for...

Philips Azurion image-guided therapy systemDoctor and patient in IndonesiaJuly 29, 2025Long-term multiyear agreements will see Philips installing its advanced Azurion image-guided therapy systems nationwide across all provinces, including rural and remote areas Initiative brings minimally invasive care to millions of cardiac, stroke and cancer patients in Indonesia Combines cutting-edge treatment technology, services and training to strengthen Indonesia’s health infrastructureAmsterdam, the Netherlands and Jakarta, Indonesia – In a major step toward transforming healthcare delivery, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and the Indonesia’s Ministry of Health today announced plans to deploy state-of-the-art image-guided therapy systems nationwide, as part of their signed agreements,...

Amundi: First half and second quarter 2025 results Record inflows of +€52bn in the first half of the yearInflowsalready at full year 2024 level   Assets under management1 at an all-time high of €2.27tn at end-June 2025, +5% June/June despite the negative forex effect Net inflows +€52bn in H1, of which +€20bn in Q2+€48bn in medium-to-long-term assets2 (MLT) in H1 Record half-year net inflows for Institutionals: +€31bn     Growth in profit before tax   First half 2025: profit before tax3,4 €895m, up +4% H1/H14:Driven by revenue growth (+5%) Cost control, with a cost-income ratio at 52.5%3     Continued success on strategic pillars   Partnership with Victory Capital finalised on 1 AprilStrong H1 inflows in strategic priorities:Third-party...

SDHG market cap hit HK$100 billion for the first time, as stock price surged 200+ percent in 2025 From 2021 to 2024, SDHG’s total assets more than tripled, from RMB 21.43 billion to RMB 66.17 billion Dazzling success attributed to SDHG’s two-pronged strategy of smart investing in new energy and computing power Electricity-Computing Integration model places SDHG in unique position to lead industry SDHG’s outstanding ability to align key businesses with national policy priorities wins dedicated government supportHONG KONG, July 29, 2025 (GLOBE NEWSWIRE) — Shandong Hi-Speed Holdings Group Ltd. (00412.HK) shares rose to HK$17.26 at closing on Monday, July 28, sending the market cap of the strongly growing company to HK$103.9 billion. SDHG market cap exceeded HK$100 billion for the first time on July 11. The fact that it has since...

Ad Hoc announcement pursuant to Article 53 of the Listing Rules of the SIX Exchange Regulation  SIKA ACHIEVES GLOBAL GROWTH OF 1.6% IN LOCAL CURRENCIES AND EXPANDS ITS PROFIT MARGINSales of CHF 5,676.4 million (previous year: CHF 5,834.8 million) in first half of the year 1.6% sales increase in local currencies, with 0.6% attributable to organic growth and 1.0% to acquisition effect Weaker US dollar predominantly responsible for high foreign currency impact of -4.3% Material margin at a consistently high level of 55.1% (previous year: 55.1%) EBITDA margin increased to 18.9% (previous year: 18.7%), supported by strong synergy momentum; raised MBCC synergy targets for 2025 and 2026 by CHF 20 million Targeted investments in future growth:Strategic acquisition of Elmich (Singapore), Cromar (UK), HPS (USA), and Gulf Additive (Qatar) Global...